Clinical Trial Information Request for Protocol 24-155 Title Phase Ib study of Axatilimab in Combination with Olaparib in BRCA1/2 and PALB2-associated metastatic HER2-negative breast cancer PI Site Directions: Type your name, contact email and phone number (optional) into the boxes below then click Save to Submit your request for information about this study. Name Email Phone